To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene WDFY2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
303 supporting clones for gene WDFY2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
T24113   .a 1 to 219 219 to 1   tiling clone,   219/219
(100 %)
0 diff
(100 %id)
DA086607 cerebellum .a 165 to 654 2 to 491   tiling clone, capped   490/490
(100 %)
1 diff
(99.8 %id)
NM_052950.3   .a 318 to 4126 1 to 3809   RefSeq,   3809/3809
(100 %)
0 diff
(100 %id)
DA124107 cerebellum .a 319 to 870 2 to 553   capped   552/559
(98 %)
5 diff
(99.2 %id)
BP351370   .a 393 to 795 1 to 403       403/582
(69 %)
8 diff
(98.7 %id)
BX955255   .a 418 to 1087 1 to 670       670/670
(100 %)
1 diff
(99.9 %id)
DB456670 testis .a 425 to 895 1 to 471       471/481
(97 %)
2 diff
(99.6 %id)
DA700134   .a 428 to 936 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
DA960349 Spleen .a 428 to 983 2 to 557   capped   556/558
(99 %)
3 diff
(99.5 %id)
DB114897 thymus .a 428 to 898 2 to 472   capped   471/471
(100 %)
0 diff
(100 %id)
DA077618 cerebellum .a 431 to 991 2 to 564   capped   563/564
(99 %)
2 diff
(99.7 %id)
DA664594   .a 432 to 987 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA814496   .a 432 to 972 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DA998222   .a 432 to 1000 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA034487   .a 433 to 969 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA322021 hippocampus .a 433 to 1051 2 to 623   capped   622/625
(99 %)
7 diff
(98.9 %id)
DA699660   .a 433 to 936 2 to 505   capped   504/504
(100 %)
1 diff
(99.9 %id)
DA851779 placenta .a 433 to 993 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA854381 placenta .a 433 to 999 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DB120217 thymus .a 433 to 991 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA602652   .a 435 to 998 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA699897   .a 435 to 936 2 to 503   capped   502/502
(100 %)
0 diff
(100 %id)
DB012046 esophageal, tumor tissue .a 435 to 1003 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DB092065 testis .a 435 to 977 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB122957 thymus .a 435 to 972 2 to 540   capped   539/539
(100 %)
2 diff
(99.7 %id)
DB148231 thymus .a 435 to 991 2 to 558   capped   557/564
(98 %)
3 diff
(99.5 %id)
DB157534 thymus .a 435 to 1038 2 to 605   capped   604/604
(100 %)
1 diff
(99.9 %id)
DB285057 uterus .a 435 to 978 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
BQ431026 melanotic melanoma, skin .a 448 to 1109 1 to 666       666/949
(70 %)
16 diff
(98.4 %id)
BP315409 mammary gland .a 450 to 1030 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DA664947   .a 451 to 998 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
DA840687 placenta .a 451 to 1004 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DB196696 trachea .a 456 to 1028 2 to 575   capped   574/578
(99 %)
2 diff
(99.7 %id)
TI_57235968   .a 458 to 1290 19 to 860       839/860
(97 %)
27 diff
(96.9 %id)
DA625246 Kidney .a 459 to 1000 2 to 544   capped   543/543
(100 %)
3 diff
(99.5 %id)
DA042016 bladder .a 461 to 998 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA221993 brain .a 461 to 1011 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA261701 caudate nucleus .a 461 to 912 2 to 453   capped   452/452
(100 %)
0 diff
(100 %id)
DA870743 Prostate .a 462 to 999 2 to 540   capped   539/539
(100 %)
6 diff
(98.9 %id)
BP241232 Liver .a 463 to 1032 1 to 570       570/570
(100 %)
8 diff
(98.6 %id)
AL526775 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 464 to 795 1 to 334       334/334
(100 %)
5 diff
(98.6 %id)
DB015216 esophageal, tumor tissue .a 464 to 998 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DA757642   .a 466 to 964 2 to 504   capped   503/503
(100 %)
4 diff
(99.3 %id)
DA798683 brain .a 466 to 1028 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BI910413 leukocyte .a 467 to 1094 1 to 629       629/629
(100 %)
3 diff
(99.6 %id)
DA566558 heart .a 472 to 1042 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BE247354 leukopheresis .a 472 to 706 1 to 236       236/236
(100 %)
4 diff
(98.4 %id)
DA417957 thalamus .a 473 to 1014 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
BF310787 brain, neuroblastoma .a 475 to 1142 1 to 667       667/1039
(64 %)
14 diff
(98.7 %id)
BM912212 amelanotic melanoma, cell line, skin .a 475 to 792 1 to 318       318/1269
(25 %)
5 diff
(99.7 %id)
BC014004 Placenta, choriocarcinoma .a 478 to 2087 1 to 1610   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1610/1610
(100 %)
0 diff
(100 %id)
BF306825 muscle, rhabdomyosarcoma .a 478 to 1190 1 to 705       705/893
(78 %)
21 diff
(97.7 %id)
DA542713   .a 480 to 1260 2 to 783   capped   782/803
(97 %)
11 diff
(98.7 %id)
BI837394 pooled pancreas and spleen .a 480 to 1260 1 to 783       783/785
(99 %)
14 diff
(98.3 %id)
CX785346 human embryonic stem cells .a 480 to 1289 1 to 810       810/810
(100 %)
0 diff
(100 %id)
TI_57165272   .a 480 to 1260 32 to 814       783/816
(95 %)
16 diff
(98.1 %id)
BM804744 ovary (pool of 3) .a 483 to 1416 1 to 942       942/942
(100 %)
17 diff
(98.2 %id)
BE733409 choriocarcinoma, placenta .a 498 to 1231 1 to 745       745/745
(100 %)
35 diff
(95.4 %id)
DA477718   .a 506 to 1072 2 to 572   capped   571/571
(100 %)
4 diff
(99.3 %id)
BE298977 muscle, rhabdomyosarcoma .a 514 to 1133 1 to 620       620/620
(100 %)
3 diff
(99.6 %id)
CN429965 embryonic stem cells, cell lines H1, H7, andH9 .a 618 to 795 1 to 178       178/193
(92 %)
2 diff
(99.0 %id)
AF411978   .a 658 to 1860 1 to 1203 Y110C G197E D208X     1203/1203
(100 %)
3 diff
(99.8 %id)
EL733494 mixed .a 658 to 1323 1 to 659       660/659
(100 %)
7 diff
(99.0 %id)
TI_1948242414   .a 658 to 1590 127 to 1060       934/1370
(68 %)
13 diff
(99.1 %id)
TI_1948242415   .a 658 to 1590 133 to 1065       933/1426
(65 %)
36 diff
(97.5 %id)
TI_1948242699   .a 658 to 1588 127 to 1057       931/1349
(69 %)
23 diff
(98.3 %id)
TI_1948242700   .a 658 to 1587 131 to 1058       928/1402
(66 %)
28 diff
(98.1 %id)
TI_1948242983   .a 658 to 1585 124 to 1050       925/1360
(68 %)
12 diff
(99.2 %id)
TI_1948242984   .a 658 to 1590 129 to 1069       941/1488
(63 %)
33 diff
(97.8 %id)
TI_1948243274   .a 658 to 1487 128 to 960       833/1449
(57 %)
22 diff
(98.5 %id)
TI_1948243275   .a 658 to 1563 125 to 1027       811/1400
(57 %)
31 diff
(97.8 %id)
CB217004 normal endometrium, mid-secretory phase,cycle day 23, uterus .a 671 to 1379 1 to 708       708/708
(100 %)
1 diff
(99.9 %id)
CF141356 CNCAP(3)T-225 cell line, Prostate .a 738 to 1185 1 to 448       448/448
(100 %)
4 diff
(99.2 %id)
TI_154172077   .a 744 to 1343 77 to 677       601/602
(99 %)
13 diff
(97.9 %id)
BF350932 head_neck .a 937 to 1427 492 to 1       492/512
(96 %)
3 diff
(99.5 %id)
BG338595 leiomyosarcoma cell line, uterus .a 990 to 1590 1 to 609       609/1022
(59 %)
18 diff
(98.3 %id)
TI_1948242985   .a 990 to 1859 1001 to 129       873/1298
(67 %)
26 diff
(98.0 %id)
TI_1948243276   .a 990 to 1859 1000 to 127       874/1282
(68 %)
23 diff
(98.3 %id)
TI_1948242701   .a 998 to 1859 997 to 127       871/1326
(65 %)
20 diff
(98.5 %id)
TI_1948242702   .a 1054 to 1859 937 to 124       814/1479
(55 %)
19 diff
(98.8 %id)
TI_1948242986   .a 1143 to 1859 839 to 122       718/1486
(48 %)
6 diff
(99.6 %id)
AL562744 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1146 to 2195 1049 to 1       1049/1049
(100 %)
18 diff
(98.3 %id)
BM797002 Ascites, stomach .a 1174 to 1530 1 to 357       357/357
(100 %)
1 diff
(99.8 %id)
AW674049 cervix .a 1218 to 1428 1 to 211       211/214
(98 %)
3 diff
(98.6 %id)
TI_154046635   .a 1253 to 2087 907 to 77   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 831/987
(84 %)
11 diff
(98.9 %id)
CA412501 Chondrosarcoma Grade II, Left Pelvis .a 1310 to 2087 795 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 777/777
(100 %)
3 diff
(99.7 %id)
TI_149311132   .a 1378 to 2095 822 to 107   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 716/905
(79 %)
6 diff
(99.4 %id)
TI_1948242416   .a 1386 to 1859 604 to 131       474/1314
(36 %)
8 diff
(99.4 %id)
T87541 liver and spleen .a 1486 to 1791 1 to 306   fully sequenced,   306/306
(100 %)
0 diff
(100 %id)
H70262 liver and spleen .a 1486 to 1799 1 to 314   fully sequenced,   314/314
(100 %)
1 diff
(99.7 %id)
AA703241 liver and spleen .a 1486 to 2084 599 to 1       599/599
(100 %)
0 diff
(100 %id)
T97470 liver and spleen .a 1487 to 1823 1 to 338   fully sequenced,   338/338
(100 %)
1 diff
(99.8 %id)
AA004280 liver and spleen .a 1491 to 1692 1 to 202       202/202
(100 %)
0 diff
(100 %id)
T97877 liver and spleen .a 1530 to 1622 1 to 95       95/100
(95 %)
3 diff
(97.0 %id)
BF818089 colon_ins .a 1582 to 2020 1 to 438       438/438
(100 %)
9 diff
(98.0 %id)
CA425083 cell lines, Chondrosarcoma .a 1600 to 2087 503 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 488/488
(100 %)
3 diff
(99.4 %id)
CR612847 B cells (Ramos cell line) Cot 25-normalized .a 1623 to 2509 1 to 887       887/887
(100 %)
0 diff
(100 %id)
BX363773   .a 1623 to 2509 1 to 887   fully sequenced,   887/887
(100 %)
0 diff
(100 %id)
AA701982 liver and spleen .a 1626 to 2084 459 to 1       459/459
(100 %)
0 diff
(100 %id)
AI057330 liver and spleen .a 1630 to 2088 459 to 1       459/459
(100 %)
0 diff
(100 %id)
CU444232 epidermis .a 1640 to 1961 332 to 10     Submitted on the opposite strand 323/340
(95 %)
1 diff
(99.8 %id)
CU449022 epidermis .a 1640 to 1961 332 to 10     Submitted on the opposite strand 323/340
(95 %)
1 diff
(99.8 %id)
CU452723 epidermis .a 1640 to 1961 332 to 10     Submitted on the opposite strand 323/340
(95 %)
1 diff
(99.8 %id)
DB525553 testis .a 1657 to 2100 1 to 444     Submitted on the opposite strand 444/444
(100 %)
0 diff
(100 %id)
BQ333200 lung_tumor .a 1677 to 2030 1 to 357       357/383
(93 %)
21 diff
(94.6 %id)
AA716631 heart .a 1705 to 2087 383 to 1       383/383
(100 %)
1 diff
(99.8 %id)
BE245867 leukopheresis .a 1751 to 2262 513 to 2       512/513
(99 %)
2 diff
(99.7 %id)
DA509256 brain .a 1758 to 2329 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
T87542 liver and spleen .a 1761 to 2090 336 to 4   fully sequenced,   333/336
(99 %)
0 diff
(100 %id)
H70263 liver and spleen .a 1769 to 2090 343 to 10   fully sequenced,   334/343
(97 %)
9 diff
(97.4 %id)
AA864300 pooled germ cell tumors .a 1773 to 2087 341 to 27   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 315/315
(100 %)
0 diff
(100 %id)
T97471 liver and spleen .a 1793 to 2090 310 to 5   fully sequenced,   306/310
(98 %)
2 diff
(99.4 %id)
AI240613 pooled .a 1793 to 2087 308 to 15   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 294/295
(99 %)
1 diff
(99.7 %id)
BX363772   .a 1800 to 2471 672 to 1   fully sequenced,   672/672
(100 %)
3 diff
(99.6 %id)
R69683 placenta .a 1803 to 2199 1 to 402   fully sequenced,   402/402
(100 %)
11 diff
(97.3 %id)
T95641 liver and spleen .a 1810 to 2063 256 to 1       256/257
(99 %)
3 diff
(98.9 %id)
TI_157601020   .a 1829 to 2507 759 to 87       673/994
(67 %)
0 diff
(100 %id)
BE182988 head_neck .a 1911 to 2039 137 to 5     Submitted on the opposite strand 133/137
(97 %)
0 diff
(100 %id)
BE536078 cervix .a 1914 to 2468 1 to 549       549/826
(66 %)
12 diff
(98.6 %id)
BM967195 Islets of Langerhans, Pancreas .a 1971 to 2543 1 to 573       573/573
(100 %)
0 diff
(100 %id)
CA308078 Alveolar Macrophage, lung .a 1988 to 2579 608 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 593/593
(100 %)
3 diff
(99.5 %id)
GD145948   .a 1998 to 2097 1 to 100       100/112
(89 %)
3 diff
(97.4 %id)
GD145605   .a 2015 to 2090 1 to 76       76/80
(95 %)
1 diff
(98.8 %id)
AA845630 parathyroid gland, parathyroid tumor .a 2059 to 2567 512 to 5       508/512
(99 %)
0 diff
(100 %id)
DB522091 testis .a 2083 to 2576 1 to 494   tiling clone, Submitted on the opposite strand 494/494
(100 %)
1 diff
(99.8 %id)
AW673842 cervix .a 2087 to 2567 483 to 3       481/483
(99 %)
0 diff
(100 %id)
AW299565 Kidney .a 2107 to 2567 464 to 4       461/464
(99 %)
0 diff
(100 %id)
R69595 placenta .a 2134 to 2502 386 to 1   fully sequenced,   386/386
(100 %)
25 diff
(93.6 %id)
BU536175 mixed (pool of 40 RNAs) .a 2148 to 2545 1 to 396       396/429
(92 %)
5 diff
(98.9 %id)
BP396122 pancreatic islet .a 2218 to 2543 1 to 326     Submitted on the opposite strand 326/326
(100 %)
0 diff
(100 %id)
DA812265 ovary, tumor tissue .a 2257 to 2965 2 to 714   capped   713/718
(99 %)
10 diff
(98.7 %id)
CN290845 embryonic stem cells, DMSO-treated H9 cellline .a 2355 to 2918 1 to 564       564/564
(100 %)
0 diff
(100 %id)
DA367162 subthalamic nucleus .a 2392 to 2963 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
CN290846 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2504 to 3235 1 to 732   tiling clone,   732/732
(100 %)
3 diff
(99.6 %id)
CD558410 White Matter .a 2706 to 3538 26 to 866       841/900
(93 %)
25 diff
(97.3 %id)
AI417133 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2753 to 3194 458 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 442/442
(100 %)
0 diff
(100 %id)
BX484406   .a 2803 to 3318 1 to 517       517/517
(100 %)
3 diff
(99.5 %id)
CN290844 embryonic stem cells, DMSO-treated H9 cellline .a 2858 to 3415 559 to 1     Submitted on the opposite strand 559/559
(100 %)
2 diff
(99.7 %id)
BQ309916 breast .a 2947 to 3452 506 to 3   tiling clone,   504/509
(99 %)
0 diff
(100 %id)
BF354270 head_neck .a 3036 to 3255 220 to 1       220/225
(97 %)
2 diff
(99.2 %id)
BF896640 marrow .a 3256 to 3625 1 to 371       371/375
(98 %)
12 diff
(96.8 %id)
BF898095 marrow .a 3278 to 3605 1 to 330       330/332
(99 %)
11 diff
(96.7 %id)
CN355524 embryonic stem cells, cell lines H1, H7, andH9 .a 3386 to 3579 8 to 200       193/200
(96 %)
6 diff
(97.0 %id)
AL138352 melanoma (MeWo cell line) .a 3405 to 4078 1 to 676   tiling clone,   676/676
(100 %)
3 diff
(99.6 %id)
BQ574560 Chondrosarcoma Grade II, Left Pelvis .a 3478 to 4125 666 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 648/648
(100 %)
3 diff
(99.6 %id)
BQ376424 testis_normal .a 3481 to 3715 238 to 6       233/249
(93 %)
0 diff
(100 %id)
CN355523 embryonic stem cells, cell lines H1, H7, andH9 .a 3488 to 4195 1 to 706   tiling clone,   706/706
(100 %)
3 diff
(99.6 %id)
DB316249 brain .a 3587 to 4125 539 to 1       539/539
(100 %)
0 diff
(100 %id)
BM893873 Islets of Langerhans, Pancreas .a 3595 to 4126 532 to 1       532/532
(100 %)
1 diff
(99.9 %id)
DB371605 ovary, tumor tissue .a 3626 to 4125 498 to 1       498/564
(88 %)
6 diff
(99.0 %id)
AK309815 brain .b 1 to 1274 1 to 1276 H239Q tiling clone,   1276/1276
(100 %)
2 diff
(99.9 %id)
GD148614   .b 1194 to 1274 1 to 81   AAA   81/81
(100 %)
3 diff
(96.3 %id)
BQ371866 prostate_normal .b 1208 to 1839 636 to 5       632/636
(99 %)
0 diff
(100 %id)
CV571355 cornea, eye .b 1256 to 1841 1 to 586   tiling clone,   586/586
(100 %)
1 diff
(99.9 %id)
BF877546 lung_tumor .b 1591 to 2046 459 to 4     Submitted on the opposite strand 456/461
(98 %)
0 diff
(100 %id)
BF877554 lung_tumor .b 1593 to 2087 499 to 4     Submitted on the opposite strand 496/499
(99 %)
0 diff
(100 %id)
BG913835 anaplastic oligodendroglioma with 1p/19qloss, brain .b 1713 to 2427 11 to 730   tiling clone,   720/730
(98 %)
6 diff
(99.2 %id)
BF673801 Prostate .b 1986 to 2654 1 to 657       657/857
(76 %)
20 diff
(97.7 %id)
AV645701 corresponding non cancerous liver tissue .b 2210 to 2586 22 to 397   tiling clone, Submitted on the opposite strand 376/397
(94 %)
6 diff
(98.5 %id)
BM720143 eye, fetal eye .b 2490 to 2975 1 to 485   tiling clone,   485/485
(100 %)
3 diff
(99.4 %id)
BF368651 placenta_normal .b 2570 to 2919 358 to 10       349/358
(97 %)
0 diff
(100 %id)
BU616176 Bone, Subchondral Bone .b 2765 to 3539 792 to 19   tiling clone, AAA   774/774
(100 %)
3 diff
(99.7 %id)
BE768336 prostate_tumor .b 2826 to 3167 1 to 358       358/358
(100 %)
28 diff
(92.2 %id)
BE768331 prostate_tumor .b 2849 to 3163 1 to 317       317/317
(100 %)
15 diff
(95.3 %id)
BE768187 prostate_tumor .b 2961 to 3275 321 to 7       315/321
(98 %)
0 diff
(100 %id)
AV712778   .b 3010 to 3378 29 to 393       365/430
(84 %)
19 diff
(95.6 %id)
BX119158   .b 3019 to 3400 382 to 1     Submitted on the opposite strand 382/384
(99 %)
5 diff
(98.7 %id)
BM672061 eye, fetal eye .b 3025 to 3717 693 to 1   tiling clone,   693/693
(100 %)
0 diff
(100 %id)
AI138268   .b 3026 to 3367 1 to 342     Submitted on the opposite strand 342/342
(100 %)
3 diff
(99.2 %id)
AI126302   .b 3026 to 3367 1 to 342     Submitted on the opposite strand 342/342
(100 %)
3 diff
(99.2 %id)
BE768095 prostate_tumor .b 3039 to 3271 240 to 6       235/240
(97 %)
0 diff
(100 %id)
AI475902 B-cell, chronic lymphotic leukemia .b 3249 to 3701 454 to 1       454/454
(100 %)
1 diff
(99.8 %id)
AI567388 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 3285 to 3539 255 to 1       255/255
(100 %)
0 diff
(100 %id)
AI254242 colon, moderately-differentiated adenocarcinoma .b 3351 to 3701 352 to 1       352/352
(100 %)
1 diff
(99.8 %id)
DA833916 placenta .b 3698 to 4510 2 to 817   tiling clone, capped   816/817
(99 %)
17 diff
(98.0 %id)
DB262609 uterus .b 3802 to 4367 2 to 567   tiling clone, capped   566/566
(100 %)
1 diff
(99.9 %id)
DB380910 placenta .b 4950 to 5492 543 to 1   tiling clone,   543/544
(99 %)
8 diff
(98.6 %id)
AK058149 testis .c 1 to 1235 1 to 1235 F259L G282R tiling clone, available from FLJ,   1235/1235
(100 %)
2 diff
(99.9 %id)
BP369881 testis .c 1 to 569 1 to 570       570/570
(100 %)
1 diff
(99.9 %id)
DR005968 Prostate .d-u 1 to 494 7 to 501 A26V D133G G134R P135A T136D ... tiling clone,   495/501
(98 %)
6 diff
(98.9 %id)
CN429964 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 1 to 633 7 to 637 exact tiling clone,   637/637
(100 %)
4 diff
(99.4 %id)
BU177302 melanotic melanoma, skin .e 30 to 768 19 to 761 exact tiling clone,   743/955
(77 %)
16 diff
(98.4 %id)
BE552161 Kidney .e 649 to 1204 556 to 2   tiling clone,   555/556
(99 %)
0 diff
(100 %id)
AW614396 Kidney .e 863 to 1314 466 to 15   tiling clone, AAA   452/452
(100 %)
0 diff
(100 %id)
AW771269 Kidney .e 943 to 1201 261 to 3       259/261
(99 %)
0 diff
(100 %id)
AI670701 Kidney .e 1269 to 1746 478 to 1   tiling clone,   478/478
(100 %)
1 diff
(99.8 %id)
DB045186 testis .f 1 to 564 2 to 565 exact tiling clone, capped   564/564
(100 %)
0 diff
(100 %id)
DB257906 uterus .f 1 to 567 2 to 568 exact capped   567/567
(100 %)
1 diff
(99.9 %id)
BP197072 adrenal gland .f 21 to 602 1 to 582 exact tiling clone,   582/582
(100 %)
0 diff
(100 %id)
DB089043 testis .g 1 to 543 2 to 548 F114L L115G Y116L C117Y Q118C ... tiling clone, capped   544/547
(99 %)
1 diff
(99.9 %id)
DA225789 brain .h-u 1 to 480 2 to 481   tiling clone, to resequence, capped   480/480
(100 %)
0 diff
(100 %id)
BE044596 pooled .h-u 49 to 512 466 to 3   tiling clone,   464/466
(99 %)
0 diff
(100 %id)
CN355525 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h-u 65 to 512 1 to 448       448/453
(98 %)
2 diff
(99.6 %id)
CB217597 mandible, pooled .h-u 149 to 512 1 to 364   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 364/397
(91 %)
1 diff
(99.8 %id)
DA340652 hippocampus .h-u 929 to 1519 2 to 593   tiling clone, capped   592/592
(100 %)
2 diff
(99.7 %id)
DA108199 cerebellum .h-u 977 to 1549 2 to 574   tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
BU431466 lymph .h-u 1027 to 1452 1 to 426   tiling clone,   426/426
(100 %)
5 diff
(98.9 %id)
DB133132 thymus .h-u 1479 to 2032 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA115680 cerebellum .h-u 1486 to 2044 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA124960 cerebellum .h-u 1548 to 2064 2 to 518   tiling clone, capped   517/517
(100 %)
0 diff
(100 %id)
DB232198 trachea .h-u 1769 to 2352 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DB136749 thymus .h-u 1822 to 2370 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
CN265330 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h-u 1918 to 2309 1 to 392       392/392
(100 %)
8 diff
(98.0 %id)
DA217042 brain .h-u 1966 to 2507 2 to 543   tiling clone, capped   542/542
(100 %)
1 diff
(99.9 %id)
DA390792 thalamus .h-u 2072 to 2650 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
BQ884105 sciatic nerve .h-u 2307 to 2907 1 to 606       606/930
(65 %)
21 diff
(97.8 %id)
AK095358 tongue, tumor tissue .h-u 2316 to 5268 1 to 2956 exact tiling clone, available from FLJ,   2956/2956
(100 %)
7 diff
(99.8 %id)
DA443942 tongue, tumor tissue .h-u 2317 to 2896 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
AW450492   .h-u 2502 to 2740 13 to 251     Submitted on the opposite strand 239/261
(91 %)
2 diff
(99.3 %id)
CD358198 testis .h-u 2845 to 3628 1 to 786       786/896
(87 %)
7 diff
(99.3 %id)
DA954723 Spleen .h-u 2925 to 3470 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
DN993501 brain, whole brain .h-u 3083 to 3673 1 to 591       591/591
(100 %)
5 diff
(99.2 %id)
DB174400 kidney, tumor tissue .h-u 3174 to 3741 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
BU520776 leiomyosarcoma, uterus .h-u 3308 to 4042 1 to 739 exact     739/799
(92 %)
6 diff
(99.3 %id)
AV709650 adrenal gland .h-u 3520 to 4221 1 to 701       701/701
(100 %)
8 diff
(98.9 %id)
CN282220 embryonic stem cells, cell lines H1, H7, andH9 .h-u 3693 to 4409 13 to 729       717/729
(98 %)
6 diff
(99.2 %id)
AA340335 brain .h-u 3766 to 4029 1 to 264       264/264
(100 %)
0 diff
(100 %id)
N54762 multiple sclerosis lesions .h-u 3788 to 4192 1 to 411       411/444
(92 %)
9 diff
(98.0 %id)
AW956395   .h-u 3797 to 4372 1 to 573       573/574
(99 %)
16 diff
(97.3 %id)
CX872043 embryonic stem .h-u 3892 to 4630 1 to 739   tiling clone,   739/739
(100 %)
0 diff
(100 %id)
BU102054   .h-u 4177 to 4807 1 to 631       631/631
(100 %)
0 diff
(100 %id)
BX644610   .h-u 4276 to 4973 1 to 698       698/698
(100 %)
1 diff
(99.9 %id)
TI_154045160   .h-u 4401 to 5274 946 to 85   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 862/984
(87 %)
14 diff
(98.6 %id)
BM684717 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h-u 4438 to 5206 1 to 768   tiling clone, Submitted on the opposite strand 768/768
(100 %)
6 diff
(99.3 %id)
W05847 lung .h-u 4462 to 4965 1 to 487   fully sequenced,   487/487
(100 %)
4 diff
(99.2 %id)
CA311224 Human Lung Epithelial cells, lung .h-u 4515 to 5268 772 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 754/754
(100 %)
4 diff
(99.5 %id)
BF216444 brain, glioblastoma .h-u 4532 to 5173 1 to 634       634/866
(73 %)
27 diff
(96.9 %id)
BQ773822 Chondrosarcoma Grade II, Left Pelvis .h-u 4549 to 5269 738 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 720/720
(100 %)
4 diff
(99.5 %id)
TI_57243767   .h-u 4633 to 5449 22 to 837       816/838
(97 %)
14 diff
(98.4 %id)
BI917597 brain .h-u 4641 to 5449 1 to 808   tiling clone,   808/809
(99 %)
13 diff
(98.4 %id)
BQ956233 sciatic nerve .h-u 4647 to 5264 1 to 618       618/629
(98 %)
2 diff
(99.7 %id)
N45312 multiple sclerosis lesions .h-u 4650 to 5274 625 to 1       625/625
(100 %)
13 diff
(98.0 %id)
BM930078 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h-u 4661 to 5267 607 to 1     Submitted on the opposite strand 607/607
(100 %)
3 diff
(99.6 %id)
CA437899 lung, Metastatic Chondrosarcoma .h-u 4661 to 5269 627 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 609/609
(100 %)
1 diff
(99.9 %id)
CA412012 Chondrosarcoma Grade II, Left Pelvis .h-u 4661 to 5274 632 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 614/614
(100 %)
1 diff
(99.9 %id)
AI761447 pooled .h-u 4704 to 5269 574 to 7       568/574
(98 %)
0 diff
(100 %id)
DB344773 thymus .h-u 4704 to 5269 566 to 1       566/566
(100 %)
1 diff
(99.9 %id)
W68519 heart .h-u 4722 to 5270 1 to 571       571/581
(98 %)
20 diff
(96.6 %id)
DB310092 hippocampus .h-u 4727 to 5269 543 to 1       543/543
(100 %)
1 diff
(99.9 %id)
DB305205 brain .h-u 4737 to 5269 534 to 1   to resequence,   534/534
(100 %)
2 diff
(99.7 %id)
AI636286 Kidney .h-u 4756 to 5267 513 to 2       512/513
(99 %)
0 diff
(100 %id)
AW381539 head_neck .h-u 4776 to 5165 1 to 390       390/390
(100 %)
3 diff
(99.3 %id)
AW381460 head_neck .h-u 4780 to 5158 372 to 1       372/372
(100 %)
20 diff
(94.7 %id)
AW381478 head_neck .h-u 4804 to 5109 1 to 304       304/304
(100 %)
6 diff
(98.1 %id)
BF435584 sciatic nerve .h-u 4804 to 5269 470 to 5       466/470
(99 %)
0 diff
(100 %id)
AI636173 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .h-u 4808 to 5267 460 to 1       460/460
(100 %)
1 diff
(99.8 %id)
AI143859 heart .h-u 4823 to 5269 455 to 9       447/455
(98 %)
0 diff
(100 %id)
BG235947 blood, lymphocyte .h-u 4850 to 5267 420 to 3       418/420
(99 %)
0 diff
(100 %id)
AA771992 parathyroid gland, parathyroid tumor .h-u 4855 to 5276 423 to 3       421/423
(99 %)
0 diff
(100 %id)
AI561031 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .h-u 4886 to 5267 393 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 382/382
(100 %)
1 diff
(99.8 %id)
AI589337 adenocarcinoma, Pancreas .h-u 4899 to 5275 397 to 21       377/397
(94 %)
0 diff
(100 %id)
AA778620   .h-u 4914 to 5270 1 to 358     Submitted on the opposite strand 358/358
(100 %)
4 diff
(98.9 %id)
AA744429 Prostate, stroma .h-u 4922 to 5267 9 to 354       346/354
(97 %)
6 diff
(98.4 %id)
AW615344 Kidney .h-u 4924 to 5267 349 to 6       344/349
(98 %)
0 diff
(100 %id)
N71104 lung .h-u 4935 to 5269 335 to 1   fully sequenced,   335/335
(100 %)
2 diff
(99.5 %id)
AA921991 pooled .h-u 4937 to 5268 332 to 1       332/332
(100 %)
2 diff
(99.4 %id)
AW196737 adenocarcinoma, Pancreas .h-u 4952 to 5269 327 to 10       318/327
(97 %)
0 diff
(100 %id)
AA889180 parathyroid gland, parathyroid tumor .h-u 5020 to 5267 248 to 1       248/248
(100 %)
4 diff
(98.4 %id)
AI370531   .h-u 5048 to 5270 223 to 1       223/223
(100 %)
1 diff
(99.6 %id)
AI932774 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .h-u 5051 to 5269 236 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 219/219
(100 %)
6 diff
(97.3 %id)
FN128968 breast carcinoma .h-u 5075 to 5150 1 to 74       74/74
(100 %)
3 diff
(96.0 %id)
DB206075 trachea .i 1 to 575 2 to 576   tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
CX755771 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .j 1 to 770 4 to 769   tiling clone, Submitted on the opposite strand 769/788
(97 %)
16 diff
(98.0 %id)
BX502458 Liver .j 225 to 941 1 to 716       716/716
(100 %)
5 diff
(99.4 %id)
BX952543   .j 515 to 1176 1 to 663   tiling clone,   663/663
(100 %)
1 diff
(99.9 %id)
N94768 multiple sclerosis lesions .j 762 to 1081 1 to 319   tiling clone,   319/319
(100 %)
2 diff
(99.4 %id)
AI247854 liver and spleen .j 1068 to 1541 476 to 1   tiling clone,   476/479
(99 %)
9 diff
(98.2 %id)
AI040673 liver and spleen .j 1224 to 1541 318 to 1       318/318
(100 %)
0 diff
(100 %id)
BE298558 muscle, rhabdomyosarcoma .k 1 to 614 1 to 690   tiling clone,   517/690
(74 %)
33 diff
(95.3 %id)
DB460115 testis .k 114 to 579 1 to 466   tiling clone,   466/466
(100 %)
0 diff
(100 %id)
DA370559 thalamus .l 1 to 559 2 to 560   tiling clone, capped   559/559
(100 %)
1 diff
(99.9 %id)
H81335 liver and spleen .l 285 to 684 1 to 409   tiling clone, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 409/410
(99 %)
15 diff
(96.4 %id)
AI907874 breast .l 881 to 1473 604 to 12 exact tiling clone,   593/607
(97 %)
2 diff
(99.7 %id)
BX099703 liver and spleen .l 947 to 1545 1 to 599 exact AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 599/599
(100 %)
0 diff
(100 %id)
AW079387 colon, moderately differentiated adenocarcinoma .l 980 to 1545 570 to 1 H13P C14L R15P K16Q C17V ...     570/570
(100 %)
11 diff
(98.1 %id)
BU689194 lung .l 1004 to 1553 568 to 19 exact AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 550/550
(100 %)
0 diff
(100 %id)
TI_151706569   .l 1020 to 1684 752 to 88   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 665/928
(71 %)
5 diff
(99.5 %id)
BM694445 eye, RPE and Choroid .l 1029 to 1604 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
DB310863 thalamus .l 1442 to 2002 562 to 1   tiling clone,   562/562
(100 %)
1 diff
(99.9 %id)
H81279 liver and spleen .l 1630 to 1968 370 to 26   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 345/354
(97 %)
9 diff
(97.5 %id)
DA167840 amygdala .m 1 to 562 2 to 563   tiling clone, capped   562/562
(100 %)
0 diff
(100 %id)
AK093224 testis .m 308 to 2102 1 to 1795 K87E tiling clone, available from FLJ,   1795/1795
(100 %)
4 diff
(99.8 %id)
DB027245 testis .m 309 to 927 2 to 620   capped   619/619
(100 %)
2 diff
(99.7 %id)
DB336689 testis .m 1541 to 2102 562 to 1       562/562
(100 %)
1 diff
(99.9 %id)
BF893711 marrow .n 1 to 217 1 to 217 exact tiling clone,   217/229
(94 %)
4 diff
(98.3 %id)
AK054833 cerebellum .o-u 1 to 3203 2 to 3205 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3205/3205
(100 %)
3 diff
(100.0 %id)
DA056406 cerebellum .o-u 1 to 593 2 to 594 exact capped   593/593
(100 %)
0 diff
(100 %id)
DA018145 adrenal gland .o-u 849 to 1424 2 to 578   tiling clone, capped   577/577
(100 %)
3 diff
(99.5 %id)
CB144058 Liver .o-u 1260 to 1659 1 to 401       401/401
(100 %)
1 diff
(99.8 %id)
BM724110 eye, fetal eye .o-u 1756 to 2357 1 to 602   fully sequenced,   602/602
(100 %)
0 diff
(100 %id)
FN174153 breast carcinoma .o-u 2319 to 2436 118 to 1     Submitted on the opposite strand 118/118
(100 %)
2 diff
(98.4 %id)
BM680302 eye, fetal eye .o-u 2327 to 2786 460 to 1   fully sequenced,   460/460
(100 %)
1 diff
(99.8 %id)
BQ374702 testis_normal .o-u 2406 to 2720 18 to 330       313/335
(93 %)
4 diff
(98.9 %id)
DB296617 cerebellum .o-u 2648 to 3203 557 to 1   tiling clone,   557/557
(100 %)
3 diff
(99.5 %id)
AW935276 denis_drash .o-u 3143 to 3382 1 to 240   tiling clone,   240/240
(100 %)
8 diff
(96.7 %id)
AK311177 brain .p 1 to 913 1 to 913   tiling clone,   913/913
(100 %)
0 diff
(100 %id)
DA206191 brain .p 2 to 582 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BF221717 pooled .p 860 to 1271 428 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 412/412
(100 %)
14 diff
(96.7 %id)
AA319079 adrenal gland .p 930 to 1233 1 to 304   tiling clone,   304/304
(100 %)
2 diff
(99.4 %id)
AA319523 adrenal gland .p 930 to 1224 1 to 298       298/298
(100 %)
4 diff
(98.7 %id)
AA373862 lung .p 1140 to 1453 1 to 320       320/330
(96 %)
6 diff
(98.2 %id)
AW957513   .p 1141 to 1586 1 to 446   tiling clone,   446/446
(100 %)
1 diff
(99.8 %id)
AL698716 human skeletal muscle .q-u 1 to 588 1 to 588   tiling clone,   588/588
(100 %)
0 diff
(100 %id)
TI_154153380   .q-u 155 to 736 81 to 660   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 580/580
(100 %)
9 diff
(98.5 %id)
DA810012 brain .q-u 310 to 866 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DB077400 testis .q-u 350 to 921 2 to 574   tiling clone, capped   573/573
(100 %)
2 diff
(99.7 %id)
DA113948 cerebellum .q-u 493 to 743 2 to 252   capped   251/251
(100 %)
0 diff
(100 %id)
DB291570 uterus .q-u 494 to 1070 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DA124748 cerebellum .q-u 875 to 1410 2 to 537 exact tiling clone, capped   536/536
(100 %)
0 diff
(100 %id)
DB045801 testis .r 1 to 556 2 to 557 exact tiling clone, capped   556/556
(100 %)
0 diff
(100 %id)
DB047866 testis .r 1 to 551 2 to 552 exact capped   551/551
(100 %)
0 diff
(100 %id)
DB071691 testis .s 1 to 530 2 to 531 exact tiling clone, capped   530/530
(100 %)
0 diff
(100 %id)
AI801134 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .t-u 1 to 465 465 to 1 exact tiling clone,   465/465
(100 %)
0 diff
(100 %id)
BP431656   .u-u 1 to 371 1 to 369 F18L tiling clone,   369/369
(100 %)
3 diff
(99.2 %id)
AI457228 carcinoid, lung .u-u 58 to 441 1 to 384   tiling clone, Submitted on the opposite strand 384/384
(100 %)
0 diff
(100 %id)
DA193629 amygdala Gene WDFY2, variant not shown       capped Suspected internal deletion, this clone was ignored    
AV712117   Gene WDFY2, variant not shown         Suspected internal deletion, this clone was ignored    
AV715031   Gene WDFY2, variant not shown         Suspected internal deletion, this clone was ignored    
AV688419 hepatocellular carcinoma Gene WDFY2, variant not shown         Suspected internal deletion, this clone was ignored    
AV693350 hepatocellular carcinoma Gene WDFY2, variant not shown         Suspected internal deletion, this clone was ignored    
AA157443 Pancreas Gene WDFY2, variant not shown         This clone was ignored    
AA157881 Pancreas Gene WDFY2, variant not shown         This clone was ignored    
AW293522   Gene WDFY2, variant not shown         This clone was ignored    
BM987220 mixed Gene WDFY2, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BQ888546 ductal carcinoma, cell line, Pancreas Gene WDFY2, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u, .e, .f, .g, .h-u, .i, .j, .k, .l, .m, .n, .o-u, .p, .q-u, .r, .s, .t-u, .u-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C